A citation-based method for searching scientific literature

Natalia Palacios, Xiang Gao, Marjorie L McCullough, Eric J Jacobs, Alpa V Patel, Tinisha Mayo, Michael A Schwarzschild, Alberto Ascherio. Mov Disord 2011
Times Cited: 98







List of co-cited articles
1063 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Type 2 diabetes and the risk of Parkinson's disease.
Gang Hu, Pekka Jousilahti, Siamak Bidel, Riitta Antikainen, Jaakko Tuomilehto. Diabetes Care 2007
289
47

Diabetes and risk of Parkinson's disease.
Qun Xu, Yikyung Park, Xuemei Huang, Albert Hollenbeck, Aaron Blair, Arthur Schatzkin, Honglei Chen. Diabetes Care 2011
163
38

Diabetes and risk of Parkinson's disease: a systematic review and meta-analysis.
Emanuele Cereda, Michela Barichella, Carlo Pedrolli, Catherine Klersy, Erica Cassani, Riccardo Caccialanza, Gianni Pezzoli. Diabetes Care 2011
137
30

Risk of Parkinson disease onset in patients with diabetes: a 9-year population-based cohort study with age and sex stratifications.
Yu Sun, Ya-Hui Chang, Hua-Fen Chen, Ying-Hwa Su, Hui-Fang Su, Chung-Yi Li. Diabetes Care 2012
121
30

Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease.
Kelly Claire Simon, Honglei Chen, Michael Schwarzschild, Alberto Ascherio. Neurology 2007
161
29

Prospective cohort study of type 2 diabetes and the risk of Parkinson's disease.
Jane A Driver, Ashley Smith, Julie E Buring, J Michael Gaziano, Tobias Kurth, Giancarlo Logroscino. Diabetes Care 2008
105
29

Diabetes and the risk of developing Parkinson's disease in Denmark.
Eva Schernhammer, Johnni Hansen, Kathrine Rugbjerg, Lene Wermuth, Beate Ritz. Diabetes Care 2011
117
28

Body mass index and the risk of Parkinson disease.
G Hu, P Jousilahti, A Nissinen, R Antikainen, M Kivipelto, J Tuomilehto. Neurology 2006
129
27

Shared dysregulated pathways lead to Parkinson's disease and diabetes.
Jose A Santiago, Judith A Potashkin. Trends Mol Med 2013
137
25

Association between diabetes and subsequent Parkinson disease: A record-linkage cohort study.
Eduardo De Pablo-Fernandez, Raph Goldacre, Julia Pakpoor, Alastair J Noyce, Thomas T Warner. Neurology 2018
108
22

Obesity and the risk of Parkinson's disease.
Honglei Chen, Shumin M Zhang, Michael A Schwarzschild, Miguel A Hernán, Walter C Willett, Alberto Ascherio. Am J Epidemiol 2004
72
29

Parkinson's disease, insulin resistance and novel agents of neuroprotection.
Iciar Aviles-Olmos, Patricia Limousin, Andrew Lees, Thomas Foltynie. Brain 2013
185
21

Diabetes preceding Parkinson's disease onset. A case-control study.
Marco D'Amelio, Paolo Ragonese, Graziella Callari, Norma Di Benedetto, Barbara Palmeri, Valeria Terruso, Giuseppe Salemi, Giorgia Famoso, Paolo Aridon, Giovanni Savettieri. Parkinsonism Relat Disord 2009
48
39

Midlife adiposity and the future risk of Parkinson's disease.
R D Abbott, G W Ross, L R White, J S Nelson, K H Masaki, C M Tanner, J D Curb, P L Blanchette, J S Popper, H Petrovitch. Neurology 2002
109
18

Clinical features of Parkinson disease when onset of diabetes came first: A case-control study.
E Cereda, M Barichella, E Cassani, R Caccialanza, G Pezzoli. Neurology 2012
90
20

Diabetes and risk of Parkinson's disease: an updated meta-analysis of case-control studies.
Lin Lu, Deng-Lei Fu, Hui-Qin Li, Ai-Ju Liu, Ji-Huang Li, Guo-Qing Zheng. PLoS One 2014
71
25

Increased risk of Parkinson disease with diabetes mellitus in a population-based study.
Yu-Wan Yang, Teng-Fu Hsieh, Chia-Ing Li, Chiu-Shong Liu, Wen-Yuan Lin, Jen-Huai Chiang, Tsai-Chung Li, Cheng-Chieh Lin. Medicine (Baltimore) 2017
61
29

Dementia is associated with insulin resistance in patients with Parkinson's disease.
Domenico Bosco, Massimiliano Plastino, Dario Cristiano, Carmela Colica, Caterina Ermio, Matteo De Bartolo, Pasquale Mungari, Giulia Fonte, Domenico Consoli, Arturo Consoli,[...]. J Neurol Sci 2012
80
21

Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson's disease occurring with Type 2 diabetes in a Taiwanese population cohort.
Mark L Wahlqvist, Meei-Shyuan Lee, Chih-Cheng Hsu, Shao-Yuan Chuang, Jiunn-Tay Lee, Hsin-Ni Tsai. Parkinsonism Relat Disord 2012
145
16

Exenatide and the treatment of patients with Parkinson's disease.
Iciar Aviles-Olmos, John Dickson, Zinovia Kefalopoulou, Atbin Djamshidian, Peter Ell, Therese Soderlund, Peter Whitton, Richard Wyse, Tom Isaacs, Andrew Lees,[...]. J Clin Invest 2013
278
16

Diabetes is associated with postural instability and gait difficulty in Parkinson disease.
Vikas Kotagal, Roger L Albin, Martijn L T M Müller, Robert A Koeppe, Kirk A Frey, Nicolaas I Bohnen. Parkinsonism Relat Disord 2013
61
26

Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial.
Dilan Athauda, Kate Maclagan, Simon S Skene, Martha Bajwa-Joseph, Dawn Letchford, Kashfia Chowdhury, Steve Hibbert, Natalia Budnik, Luca Zampedri, John Dickson,[...]. Lancet 2017
339
16


Risk of Parkinson Disease in Diabetes Mellitus: An Updated Meta-Analysis of Population-Based Cohort Studies.
Xuejing Yue, Hehua Li, Haiqing Yan, Ping Zhang, Li Chang, Tong Li. Medicine (Baltimore) 2016
79
20

Case-control study of risk of Parkinson's disease in relation to hypertension, hypercholesterolemia, and diabetes in Japan.
Yoshihiro Miyake, Keiko Tanaka, Wakaba Fukushima, Satoshi Sasaki, Chikako Kiyohara, Yoshio Tsuboi, Tatsuo Yamada, Tomoko Oeda, Takami Miki, Nobutoshi Kawamura,[...]. J Neurol Sci 2010
84
17

Association between Parkinson's disease and diabetes: Data from NEDICES study.
E De Pablo-Fernandez, F Sierra-Hidalgo, J Benito-León, F Bermejo-Pareja. Acta Neurol Scand 2017
35
42

Association of blood pressure and hypertension with the risk of Parkinson disease: the National FINRISK Study.
Chengxuan Qiu, Gang Hu, Miia Kivipelto, Tiina Laatikainen, Riitta Antikainen, Laura Fratiglioni, Pekka Jousilahti, Jaakko Tuomilehto. Hypertension 2011
91
15

Meta-analysis of early nonmotor features and risk factors for Parkinson disease.
Alastair J Noyce, Jonathan P Bestwick, Laura Silveira-Moriyama, Christopher H Hawkes, Gavin Giovannoni, Andrew J Lees, Anette Schrag. Ann Neurol 2012
385
14

Metabolic markers or conditions preceding Parkinson's disease: a case-control study.
Rodolfo Savica, Brandon R Grossardt, J Eric Ahlskog, Walter A Rocca. Mov Disord 2012
31
45

Diabetes mellitus and Parkinson disease.
Gennaro Pagano, Sotirios Polychronis, Heather Wilson, Beniamino Giordano, Nicola Ferrara, Flavia Niccolini, Marios Politis. Neurology 2018
92
15

Neurodegeneration in an animal model of Parkinson's disease is exacerbated by a high-fat diet.
Jill K Morris, Gregory L Bomhoff, John A Stanford, Paige C Geiger. Am J Physiol Regul Integr Comp Physiol 2010
88
14

GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism.
Yazhou Li, TracyAnn Perry, Mark S Kindy, Brandon K Harvey, David Tweedie, Harold W Holloway, Kathleen Powers, Hui Shen, Josephine M Egan, Kumar Sambamurti,[...]. Proc Natl Acad Sci U S A 2009
405
12

Insulin and neurodegenerative disease: shared and specific mechanisms.
Suzanne Craft, G Stennis Watson. Lancet Neurol 2004
578
12

Serum cholesterol levels and the risk of Parkinson's disease.
Lonneke M L de Lau, Peter J Koudstaal, Albert Hofman, Monique M B Breteler. Am J Epidemiol 2006
142
12

The epidemiology of Parkinson's disease: risk factors and prevention.
Alberto Ascherio, Michael A Schwarzschild. Lancet Neurol 2016
696
12

Diabetes, smoking, and other medical conditions in relation to Parkinson's disease risk.
Karen M Powers, Terri Smith-Weller, Gary M Franklin, W T Longstreth, Phillip D Swanson, Harvey Checkoway. Parkinsonism Relat Disord 2006
64
17

Insulin resistance impairs nigrostriatal dopamine function.
J K Morris, G L Bomhoff, B K Gorres, V A Davis, J Kim, P-P Lee, W M Brooks, G A Gerhardt, P C Geiger, J A Stanford. Exp Neurol 2011
91
12

Body mass index and risk of Parkinson's disease: a prospective cohort study.
Giancarlo Logroscino, Howard D Sesso, Ralph S Paffenbarger, I-Min Lee. Am J Epidemiol 2007
38
28

Meta-analysis: overweight, obesity, and Parkinson's disease.
Jinhu Chen, Zhenlong Guan, Liqin Wang, Guangyao Song, Boqing Ma, Yanqin Wang. Int J Endocrinol 2014
28
39



Glucagon-like peptide 1 receptor stimulation reverses key deficits in distinct rodent models of Parkinson's disease.
Alexander Harkavyi, Amjad Abuirmeileh, Rebecca Lever, Ann E Kingsbury, Christopher S Biggs, Peter S Whitton. J Neuroinflammation 2008
190
10

Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of Parkinson's disease.
Göran Bertilsson, Cesare Patrone, Olof Zachrisson, Annica Andersson, Karin Dannaeus, Jessica Heidrich, Jarkko Kortesmaa, Alex Mercer, Elisabet Nielsen, Harriet Rönnholm,[...]. J Neurosci Res 2008
240
10

Epidemiology and etiology of Parkinson's disease: a review of the evidence.
Karin Wirdefeldt, Hans-Olov Adami, Philip Cole, Dimitrios Trichopoulos, Jack Mandel. Eur J Epidemiol 2011
652
10

Reduced risk factors for vascular disorders in Parkinson disease patients: a case-control study.
Giulio Scigliano, Massimo Musicco, Paola Soliveri, Immacolata Piccolo, Gabriele Ronchetti, Floriano Girotti. Stroke 2006
140
10

Physical activity and the risk of Parkinson disease.
H Chen, S M Zhang, M A Schwarzschild, M A Hernán, A Ascherio. Neurology 2005
222
10

Metabolic inflammation exacerbates dopaminergic neuronal degeneration in response to acute MPTP challenge in type 2 diabetes mice.
Ling Wang, Ying-Qi Zhai, Li-Li Xu, Chen Qiao, Xiu-Lan Sun, Jian-Hua Ding, Ming Lu, Gang Hu. Exp Neurol 2014
63
15

Brain dopamine and obesity.
G J Wang, N D Volkow, J Logan, N R Pappas, C T Wong, W Zhu, N Netusil, J S Fowler. Lancet 2001
10


Body Mass Index and Risk of Parkinson's Disease: A Dose-Response Meta-Analysis of Prospective Studies.
Yun-Liang Wang, Yu-Tong Wang, Jin-Feng Li, Yu-Zheng Zhang, Hong-Lei Yin, Bing Han. PLoS One 2015
34
29


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.